{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T05:03:03Z","timestamp":1785042183878,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00259-019-04647-3","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T14:14:31Z","timestamp":1580739271000},"page":"1576-1584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["FDG-PET assessment and metabolic patterns in Lafora disease"],"prefix":"10.1007","volume":"47","author":[{"given":"Lorenzo","family":"Muccioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Farolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pondrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"d\u2019Orsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Michelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Freri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Canafoglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Licchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Toni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachele","family":"Bonfiglioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Civollani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Pettinato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Maietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Marotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Tinuper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1109-7296","authenticated-orcid":false,"given":"Francesca","family":"Bisulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"4647_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41582-018-0057-0","volume":"14","author":"F Nitschke","year":"2018","unstructured":"Nitschke F, Ahonen SJ, Nitschke S, Mitra S, Minassian BA. Lafora disease \u2013 from pathogenesis to treatment strategies. Nat Rev Neurol. 2018;14:606\u201317.","journal-title":"Nat Rev Neurol"},{"key":"4647_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/humu.20954","volume":"30","author":"S Singh","year":"2009","unstructured":"Singh S, Ganesh S. Lafora progressive myoclonus epilepsy: a meta-analysis of reported mutations in the first decade following the discovery of the EPM2A and NHLRC1 genes. Hum Mutat. 2009;30:715\u201323.","journal-title":"Hum Mutat"},{"key":"4647_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/archneur.1993.00540010096025","volume":"50","author":"I Drury","year":"1993","unstructured":"Drury I, Blaivas M, Abou-Khalil BW, Beydoun A. Biopsy results in a kindred with Lafora disease. Arch Neurol. 1993;50:102\u20135.","journal-title":"Arch Neurol"},{"key":"4647_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1528-1167.2006.00526.x","volume":"47","author":"V Villanueva","year":"2006","unstructured":"Villanueva V, Linera JA, G\u00f2mez-Garre P, Guti\u00e9rrez J, Serratosa JM. MRI volumetry and proton MR spectroscopy of the brain in Lafora disease. Epilepsia. 2006;47:788\u201392.","journal-title":"Epilepsia"},{"key":"4647_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1684\/epd.2016.0842","volume":"18","author":"J Turnbull","year":"2016","unstructured":"Turnbull J, Tiberia E, Striano P, et al. Lafora disease. Epileptic Disord. 2016;18:38\u201362.","journal-title":"Epileptic Disord"},{"key":"4647_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1528-1167.2009.02498.x","volume":"51","author":"M Jennesson","year":"2010","unstructured":"Jennesson M, Milh M, Villeneuve N, et al. Posterior glucose hypometabolism in Lafora disease: early and late FDG-PET assessment. Epilepsia. 2010;51:708\u201311.","journal-title":"Epilepsia."},{"key":"4647_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1046\/j.1442-200x.1999.01130.x","volume":"41","author":"Z Kato","year":"1999","unstructured":"Kato Z, Yasuda K, Ishii K, et al. Glucose metabolism evaluated by positron emission tomography in Lafora disease. Pediatr Int. 1999;41:689\u201392.","journal-title":"Pediatr Int"},{"key":"4647_CR8","first-page":"175","volume":"35","author":"H Tsuda","year":"1995","unstructured":"Tsuda H, Katsumi Y, Nakamura M, et al. Cerebral blood flow and metabolism in Lafora disease. Rinsho Shinkeigaku. 1995;35:175\u20139.","journal-title":"Rinsho Shinkeigaku"},{"key":"4647_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1177\/08830738030180070901","volume":"18","author":"SF Al Otaibi","year":"2003","unstructured":"Al Otaibi SF, Minassian BA, Ackerley CA, Logan WJ, Weiss S. Unusual presentation of Lafora\u2019s disease. J Child Neurol. 2003;18:499\u2013501.","journal-title":"J Child Neurol"},{"key":"4647_CR10","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1080\/00207454.2017.1337012","volume":"127","author":"S Casciato","year":"2017","unstructured":"Casciato S, Gambardella S, Mascia A, et al. Severe and rapidly-progressive Lafora disease associated with NHLRC1 mutation: a case report. Int J Neurosci. 2017;127:1150\u20133.","journal-title":"Int J Neurosci"},{"key":"4647_CR11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jamaneurol.2016.3195","volume":"74","author":"AL Cohen","year":"2017","unstructured":"Cohen AL, Jones LK, Parisi JE, Klaas JP. Intractable epilepsy and progressive cognitive decline in a young man. JAMA Neurol. 2017;74:737\u201340.","journal-title":"JAMA Neurol"},{"key":"4647_CR12","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/mds.20523","volume":"20","author":"E Driver-Dunkley","year":"2005","unstructured":"Driver-Dunkley E, Sirven J, Drazkowski J, Caviness JN. Lafora disease with primary generalized epileptic myoclonus. Mov Disord. 2005;20:907\u20138.","journal-title":"Mov Disord"},{"key":"4647_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/0883073811416363","volume":"27","author":"V Shandal","year":"2012","unstructured":"Shandal V, Veenstra AL, Behen M, Sundaram S, Chugani H. Long-term outcome in children with intractable epilepsy showing bilateral diffuse cortical glucose hypometabolism pattern on positron emission tomography. J Child Neurol. 2012;27:39\u201345.","journal-title":"J Child Neurol"},{"key":"4647_CR14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1528-1167.2006.00479.x","volume":"47","author":"S Franceschetti","year":"2006","unstructured":"Franceschetti S, Gambardella A, Canafoglia L, et al. Clinical and genetic findings in 26 Italian patients with Lafora disease. Epilepsia. 2006;47:640\u20133.","journal-title":"Epilepsia"},{"key":"4647_CR15","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00259-009-1264-0","volume":"36","author":"A Varrone","year":"2009","unstructured":"Varrone A, Asenbaum S, Vander Borght T, et al. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging. 2009;36:2103\u2013010.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"4647_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/jcbfm.1989.97","volume":"9","author":"KJ Friston","year":"1989","unstructured":"Friston KJ, Passingham RE, Nutt JG, Heather JD, Sawle GV, Frackowiak RS. Localisation in PET images: direct fitting of the intercommissural (AC-PC) line. J Cereb Blood Flow Metab. 1989;9(5):690\u20135.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"4647_CR17","first-page":"663","volume":"25","author":"PD Acton","year":"1998","unstructured":"Acton PD, Friston KJ. Statistical parametric mapping in functional neuroimaging: beyond PET and fMRI activation studies. Eur J Nucl Med. 1998;25(7):663\u20137.","journal-title":"Eur J Nucl Med"},{"key":"4647_CR18","unstructured":"Van Heycop Ten Ham MW, De Jager H. Progressive myoclonus epilepsy with Lafora bodies. Clinico-pathological features. Epilepsia 1963;4:95\u2013119."},{"key":"4647_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/archneur.1965.00460260062008","volume":"12","author":"GA Schwarz","year":"1965","unstructured":"Schwarz GA, Yanoff M, et al. Lafora\u2019s disease. Distinct clinico-pathologic form of Unverricht\u2019s syndrome. Arch Neurol. 1965;12:172\u201388.","journal-title":"Arch Neurol"},{"key":"4647_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10048-009-0190-4","volume":"10","author":"M Traor\u00e9","year":"2009","unstructured":"Traor\u00e9 M, Landour\u00e9 G, Motley W, et al. Novel mutation in the NHLRC1 gene in a Malian family with a severe phenotype of Lafora disease. Neurogenetics. 2009;10:319\u201323.","journal-title":"Neurogenetics"},{"key":"4647_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0074-7742(08)60296-2","volume":"22","author":"L Sokoloff","year":"1981","unstructured":"Sokoloff L. The deoxyglucose method for the measurement of local glucose utilization and the mapping of local functional activity in the central nervous system. Int Rev Neurobiol. 1981;22:287\u2013333.","journal-title":"Int Rev Neurobiol"},{"key":"4647_CR22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ. Alzheimer\u2019s disease is a synaptic failure. Science. 2002;298:789\u201391.","journal-title":"Science"},{"key":"4647_CR23","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/hmg\/11.11.1251","volume":"11","author":"S Ganesh","year":"2002","unstructured":"Ganesh S, Delgado-Escueta AV, Sakamoto T. Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum Mol Genet. 2002;11:1251\u201362.","journal-title":"Hum Mol Genet"},{"key":"4647_CR24","doi-asserted-by":"crossref","unstructured":"De Volder AG, Cirelli S, de Barsy T, et al. Neuronal ceroid-lipofuscinosis: preferential metabolic alterations in thalamus and posterior association cortex demonstrated by PET. J Neurol Neurosurg Psychiatry 1990;52:1063\u20131067.","DOI":"10.1136\/jnnp.53.12.1063"},{"key":"4647_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1528-1167.1990.tb06299.x","volume":"31","author":"MR Sperling","year":"1990","unstructured":"Sperling MR, Gur RC, Alavi A, et al. Subcortical metabolic alterations in partial epilepsy. Epilepsia. 1990;31:145\u201355.","journal-title":"Epilepsia"},{"key":"4647_CR26","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/j.0013-9580.2004.43303.x","volume":"45","author":"K Benedek","year":"2004","unstructured":"Benedek K, Juh\u00e0sz C, Muzik O, et al. Metabolic changes of subcortical structures in intractable focal epilepsy. Epilepsia. 2004;45:1100\u20135.","journal-title":"Epilepsia"},{"key":"4647_CR27","first-page":"1964","volume":"41","author":"AB Newberg","year":"2000","unstructured":"Newberg AB, Alavi A, Berlin J, et al. Ipsilateral and contralateral thalamic hypometabolism as a predictor of outcome after temporal lobectomy for seizures. J Nucl Med. 2000;41:1964\u20138.","journal-title":"J Nucl Med"},{"key":"4647_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/epi.13278","volume":"57","author":"R Agarwal","year":"2016","unstructured":"Agarwal R, Humar A, Tiwari VN, Chugani H. Thalamic abnormalities in children with continuous spike-wave during slow-wave sleep: an F-18-fluorodeoxyglucose positron emission tomography perspective. Epilepsia. 2016;57:263\u201371.","journal-title":"Epilepsia"},{"key":"4647_CR29","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1097\/00001756-200508010-00004","volume":"16","author":"JH Kim","year":"2005","unstructured":"Kim JH, Im KC, Kim JS, Lee SA, Kang JK. Correlation of interictal spike-wave with thalamic glucose metabolism in juvenile myoclonic epilepsy. Neuroreport. 2005;16:1151\u20135.","journal-title":"Neuroreport"},{"key":"4647_CR30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ejpn.2007.09.008","volume":"12","author":"A Pichiecchio","year":"2008","unstructured":"Pichiecchio A, Veggiotti P, Cardinali S, et al. Lafora disease: spectroscopy study correlated with neuropsychological findings. Eur J Paediatr Neurol. 2008;12:342\u20137.","journal-title":"Eur J Paediatr Neurol"},{"key":"4647_CR31","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1212\/01.WNL.0000156907.49247.05","volume":"64","author":"DM Andrade","year":"2005","unstructured":"Andrade DM, del Campo JM, Moro E, Minassian BA, Wennberg RA. Nonepileptic visual hallucinations in Lafora disease. Neurology. 2005;64:1311\u20132.","journal-title":"Neurology"},{"key":"4647_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2217\/fnl.13.19","volume":"8","author":"D Collerton","year":"2013","unstructured":"Collerton D, Taylor JP. Advances in the treatment of visual hallucinations in neurodegenerative diseases. Future Neurol. 2013;8:433\u201344.","journal-title":"Future Neurol"},{"key":"4647_CR33","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrneurol.2009.62","volume":"5","author":"NJ Diederich","year":"2009","unstructured":"Diederich NJ, F\u00e9nelon G, Stebbins G, Goetz CG. Hallucinations in Parkinson disease. Nat Rev Neurol. 2009;5:331\u201342.","journal-title":"Nat Rev Neurol"},{"key":"4647_CR34","doi-asserted-by":"crossref","unstructured":"Sullivan MA, Nitschke S, Steup M, Minassian BA, Nitschke F. Pathogenesis of Lafora disease: transition of soluble glycogen to insoluble polyglucosan. Int J Mol Sci. 2017;18.","DOI":"10.3390\/ijms18081743"},{"key":"4647_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/ana.410220408","volume":"22","author":"HT Chugani","year":"1987","unstructured":"Chugani HT, Phelps ME, Mazziotta JC. Positron emission tomography study of human brain functional development. Ann Neurol. 1987;22:487\u201397.","journal-title":"Ann Neurol"},{"key":"4647_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1006\/nimg.1998.0346","volume":"8","author":"P Van Bogaert","year":"1998","unstructured":"Van Bogaert P, Wikler D, Damhaut P, Hb S, Goldman S. Regional changes in glucose metabolism during brain development from the age of 6 years. Neuroimage. 1998;8:62\u20138.","journal-title":"Neuroimage"},{"issue":"Suppl.2","key":"4647_CR37","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1111\/j.1528-1157.1988.tb05797.x","volume":"29","author":"WH Theodore","year":"1988","unstructured":"Theodore WH. Antiepileptic drugs and cerebral glucose metabolism. Epilepsia. 1988;29(Suppl.2):S48\u201355.","journal-title":"Epilepsia"},{"key":"4647_CR38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1528-1157.1991.tb04671.x","volume":"32","author":"DB Leiderman","year":"1991","unstructured":"Leiderman DB, Balish M, Bromfield EB, Theodore WH. Effect of valproate on human cerebral glucose metabolism. Epilepsia. 1991;32:417\u201322.","journal-title":"Epilepsia"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04647-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-019-04647-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04647-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:10:42Z","timestamp":1608250242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-019-04647-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["4647"],"URL":"https:\/\/doi.org\/10.1007\/s00259-019-04647-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"assertion":[{"value":"3 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective analysis was approved by the local ethics committee (reference number: 18076). Written informed consent was obtained from all participants or their legal representatives.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}